Palatine takes minority stake in pharma consultancy
Palatine Private Equity has acquired a significant minority stake in a global company that plays a key role in innovation and commercialization of new medicines including the treatment of Covid-19. TranScrip is headquartered in Wokingham and offers pharmaceutical companies a wide range of specialized professional services. It is managed by the managing partner Dr. Flic